Our Technology
Pioneering Precision Cardiovascular Medicine
Cardio Diagnostics pioneered the world's first AI-driven Multi-Omics Engine for Precision Cardiovascular Medicine, an advanced platform that integrates epigenetics, genetics, and artificial intelligence to power the rapid development of transformative clinical and data solutions aimed at bending the trajectory of cardiovascular disease.
At the intersection of cutting-edge epigenetic science, advanced AI technology, and precision measurement through digital PCR, we have created a new paradigm in cardiovascular medicine, one that transforms an individual's unique DNA information into a dynamic window revealing the molecular underpinnings of cardiovascular disease.
Our mission is to transform how cardiovascular disease is detected and managed, moving the field from generalized care to truly precision cardiovascular medicine. We are starting with coronary heart disease, the world's leading cause of death, and expanding our platform to encompass the broader spectrum of cardiovascular conditions that impact millions each year.
More Than Genetics. We Measure Epigenetics.
Healthcare has historically relied on genetics to explain why some people develop disease while others do not. Genetics refers to the fixed DNA code inherited at birth that provides the foundation for traits and predispositions, such as eye and hair color. But genetics alone only explains a fraction of health outcomes.
This is especially true for cardiovascular disease, where genetics accounts for less than 20% of risk. The rest is influenced by factors that go beyond inherited DNA. Understanding these factors requires looking deeper, into epigenetics, the dynamic layer of molecular modifications that accumulate and change over time. Epigenetics creates a measurable record of how lifestyle and environment interact with our genes to leave clues related to your health.
Actionable Insights Through AI and Machine Learning
Artificial intelligence and machine learning transform how we detect, assess, and manage coronary heart disease. At Cardio Diagnostics, we pioneered the first AI-driven Multi-Omics™ engine for Precision Cardiovascular Medicine, revolutionizing how risk is identified and personalized care is delivered.
By harnessing the power of AI we move beyond one-size-fits-all approaches, delivering actionable insights that support clinical decision-making, improve outcomes, and advance precision-driven cardiovascular care.
Our proprietary AI models, trained on thousands of clinical samples, enable us to:
- Uncover meaningful interactions between genetic and epigenetic markers linked to CHD
- Generate a personalized three-year risk score for coronary heart disease event with Epi+Gen CHD™
- Detect the presence or absence of a CHD Signal with PrecisionCHD™
Our Technology
Big Data
- Epigenetic biomarkers
- Genetic biomarkers
- Clinical data
Artificial Intelligence
- Pattern recognition in datasets
- Actionable predictive models
- Laboratory translation
Clinical Lab
- Advanced DNA testing (digital PCR)
- Precision measurements
- Scalable techniques
Turning complex science into real-world solutions for cardiovascular disease
Clinical
Tests
Population
Solutions
How Our Technology Enables Earlier and More Precise Insights
Expertise
Our team unites pioneers in AI, epigenetics, and cardiovascular medicine with leading scientists and clinicians to develop robust clinical, population and biopharma solutions for real-world care.
Precision
Our clinical tests use advanced assays designed for consistent, reliable results. These tools measure genetic and epigenetic markers with precision at scale.
Data Integrity
Our platform uses large, clinically validated datasets that link biomarkers with clinical and demographic data. We continually refine these datasets, enabling our technology to stay at the the forefront of science.
Artificial Intelligence
Our advanced and proprietary AI analyzes large datasets to find disease patterns, treatment targets, and responses. This improves accuracy and provides actionable, patient-specific insights.
Scalability
Built for scale, our technology integrates diverse datasets and combines digital and TaqMan PCR assays with machine learning models. End-to-end scalability ensures our solutions can be deployed widely to reach patients worldwide.
Reusability
Our platform's modular design supports both research and clinical applications, speeding innovation and reducing costs.
- Hou K, Burch KS, Majumdar A, et al. Accurate estimation of SNP-heritability from biobank-scale data. Nat Genet. 2019;51(8):1244-1251. doi:10.1038/s41588-019-0465-0